APOE and immunity: Research highlights
- PMID: 36975090
- DOI: 10.1002/alz.13020
APOE and immunity: Research highlights
Abstract
Introduction: At the Alzheimer's Association's APOE and Immunity virtual conference, held in October 2021, leading neuroscience experts shared recent research advances on and inspiring insights into the various roles that both the apolipoprotein E gene (APOE) and facets of immunity play in neurodegenerative diseases, including Alzheimer's disease and other dementias.
Methods: The meeting brought together more than 1200 registered attendees from 62 different countries, representing the realms of academia and industry.
Results: During the 4-day meeting, presenters illuminated aspects of the cross-talk between APOE and immunity, with a focus on the roles of microglia, triggering receptor expressed on myeloid cells 2 (TREM2), and components of inflammation (e.g., tumor necrosis factor α [TNFα]).
Discussion: This manuscript emphasizes the importance of diversity in current and future research and presents an integrated view of innate immune functions in Alzheimer's disease as well as related promising directions in drug development.
Keywords: APOE; Alzheimer's disease; TREM2; amyloid beta; astrocytes; biomarkers; dementia; inflammation; microglia; neurodegeneration; neuroglia; neuroinflammation; tau.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
References
REFERENCES
-
- Thal DR, Walter J, Saido TC, Fändrich M. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease. Acta Neuropathol (Berl). 2015;129:167-182. doi:10.1007/s00401-014-1375-y
-
- Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging. 1995;16:271-278. doi:10.1016/0197-4580(95)00021-6. discussion 278-284.
-
- Jack CR, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement J Alzheimers Assoc. 2018;14:535-562. doi:10.1016/j.jalz.2018.02.018
-
- Lanoiselée H-M, Nicolas G, Wallon D, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14:e1002270. doi:10.1371/journal.pmed.1002270
-
- Wu L, Rosa-Neto P, Hsiung G-YR, et al. Early-onset familial Alzheimer's disease (EOFAD). Can J Neurol Sci J Can Sci Neurol. 2012;39:436-445. doi:10.1017/s0317167100013949
Publication types
MeSH terms
Substances
Grants and funding
- R01 AA016829/AA/NIAAA NIH HHS/United States
- R37 AG027924/AG/NIA NIH HHS/United States
- P50 MD017356/MD/NIMHD NIH HHS/United States
- R01 AG069453/AG/NIA NIH HHS/United States
- R24 AG063729/AG/NIA NIH HHS/United States
- R01 AG066198/AG/NIA NIH HHS/United States
- RF1 AG057181/AG/NIA NIH HHS/United States
- RF1 AG058852/AG/NIA NIH HHS/United States
- R01 AG067581/AG/NIA NIH HHS/United States
- T32 AG000222/AG/NIA NIH HHS/United States
- U19 AG069701/AG/NIA NIH HHS/United States
- R01 AG066395/AG/NIA NIH HHS/United States
- R01 AG054005/AG/NIA NIH HHS/United States
- RF1 AG060057/AG/NIA NIH HHS/United States
- U01 AG061356/AG/NIA NIH HHS/United States
- R01 AG066203/AG/NIA NIH HHS/United States
- R21 AG073882/AG/NIA NIH HHS/United States
- R01 AG027924/AG/NIA NIH HHS/United States
- U01 AG066757/AG/NIA NIH HHS/United States
- R01 AG072489/AG/NIA NIH HHS/United States
- R01 AG054046/AG/NIA NIH HHS/United States
- P01 AG078116/AG/NIA NIH HHS/United States
- R01 AG054491/AG/NIA NIH HHS/United States
- RF1 AG058657/AG/NIA NIH HHS/United States
- RF1 AG075992/AG/NIA NIH HHS/United States
- R01 AG076018/AG/NIA NIH HHS/United States
- P30 AG059304/AG/NIA NIH HHS/United States
- UF1 NS125488/NS/NINDS NIH HHS/United States
- R01 AG007992/AG/NIA NIH HHS/United States
- RF1 AG046205/AG/NIA NIH HHS/United States
- U01 AG058635/AG/NIA NIH HHS/United States
- R01 EY033353/EY/NEI NIH HHS/United States
- R01 AG077636/AG/NIA NIH HHS/United States
- RF1 NS130834/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous